Post-Market Research Fraud
Recently, Medtronic paid the government over $23.5 million to quiet allegations that it violated the False Claims Act by using physician payments related to post-market…
Read More »Pharma 101 – Pharmaceutical Fraud
Pharmaceutical Fraud News & Insight form the Qui Tam and False Claims Act Perspective
Contact FormCategory Archives: Medical Devices
Whistleblowers are Needed to Supplement FDA’s Limited “Scientific Base”
In 2007, a subcommittee of the FDA’s Science Board released a report which, among other things, found that the FDA had a “weak scientific base…
Read More »Relators Can Play Role in Shutting Down Production of Defective Medical Devices
In February 2015, the United States filed a pharmaceutical fraud complaint to permanently enjoin Atrium Medical Corporation, alleging that the company and several co-defendants had introduced various adulterated and misbranded…
Read More »Medtronic Settles Second False Claims Act Case This Summer…Maybe
According to the Pennsylvania Attorney General’s Office website, Medtronic Inc. has agreed to a $2.8 million settlement with the federal government and 35 states to…
Read More »